King & Wood Mallesons ( KWM ) has provided legal advice to Deutsche Beteiligungs AG (DBAG) and its DBAG Fund VI on the acquisition of the German medical engineering company Polytech Health & Aesthetics GmbH (Polytech). The signed transaction is still subject to regulatory approval.
The listed DBAG and the funds initiated and advised by DBAG invest in well-positioned, medium-sized companies which have a promising potential for development.
Pursuant to the transaction, DBAG acquires approximately 18 percent and the DBAG Fund VI approximately 76 percent of Polytech. The remaining shares are acquired by the company's management.
Polytech headquartered in Dieburg, Germany, is a European leader in developing and producing high quality silicone implants. As the only German manufacturer of such products, Polytech’s focus is on breast implants used in reconstructive surgery after diseases as well as in aesthetic plastic surgery.
The KWM team maintains a longstanding client relationship with DBAG, which is once again demonstrated by this successful transaction.
Advisors to Deutsche Beteiligungs AG:
King & Wood Mallesons LLP, Germany
Corporate / M&A / Private Equity:
Dr Christoph Brenner (partner, lead), Bernhard Schmaderer, Dr Markus Schmid, Adrian Dengler (all associates, all Munich)
EU/Competition:
Tilman Siebert (partner), Dr Michaela Westrup (counsel), Helge Aulmann (associate, all Munich)
Banking & Finance:
Sabine Schomaker (partner), Ulf Gosejacob (counsel), Dr Michael Beyer (associate, all Frankfurt)
Employment:
Dr Barbara Geck (partner), Daniela Gudat (associate, both Frankfurt)
Real Estate:
Dr Florian Biesalski (partner), Dr Christina Konzelmann (associate, both Frankfurt)
IP/IT:
Massimo Bellitto-Grillo (managing associate, Munich)
Commercial:
Francis Bellen (partner), Matei Ujica (managing associate, both Frankfurt)
King & Wood Mallesons LLP, Italy
Davide Proverbio (partner, Milan)
King & Wood Mallesons LLP, UK
Laura Brunnen (partner, London)
King & Wood Mallesons LLP, France
Pierre-Louis Périn (partner, Paris)
